Evidence map›Paper›PMID 34573428›Full record

ReviewGenes2021

p53 mRNA Metabolism Links with the DNA Damage Response.

Sivakumar Vadivel Gnanasundram, Ondrej Bonczek, Lixiao Wang, Sa Chen, Robin Fahraeus

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Ecotoxicological impacts of benzo[a]pyrene onFrontiers in immunology · 2026
    Article
  4. TheiScience · 2025
    Article
  5. Review
  6. Cells · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 4 countries.

Sivakumar Vadivel GnanasundramDepartment of Medical Biosciences, Umeå University, 901-87 Umeå, Sweden.ORCID 0000-0001-9153-0784
Ondrej BonczekDepartment of Medical Biosciences, Umeå University, 901-87 Umeå, Sweden.ORCID 0000-0003-0745-3136
Lixiao WangDepartment of Medical Biosciences, Umeå University, 901-87 Umeå, Sweden.
Sa ChenDepartment of Medical Biosciences, Umeå University, 901-87 Umeå, Sweden.
Robin FahraeusDepartment of Medical Biosciences, Umeå University, 901-87 Umeå, Sweden.
Umeå University · SEInserm · FRMasaryk Memorial Cancer Institute · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human cells are subjected to continuous challenges by different genotoxic stress attacks. DNA damage leads to erroneous mutations, which can alter the function of oncogenes or tumor suppressors, resulting in cancer development. To circumvent this, cells activate the DNA damage response (DDR), which mainly involves cell cycle regulation and DNA repair processes. The tumor suppressor p53 plays a pivotal role in the DDR by halting the cell cycle and facilitating the DNA repair processes. Various pathways and factors participating in the detection and repair of DNA have been described, including scores of RNA-binding proteins (RBPs) and RNAs. It has become increasingly clear that p53's role is multitasking, and p53 mRNA regulation plays a prominent part in the DDR. This review is aimed at covering the p53 RNA metabolism linked to the DDR and highlights the recent findings.

Indexed as

DNA DamageDNA RepairAnimalsHumansMutationRNA-Binding ProteinsRNA, MessengerTumor Suppressor Protein p53Untranslated RegionsRNA-Binding ProteinsRNA, MessengerTumor Suppressor Protein p53Untranslated RegionsATM kinaseDNA damage responseMDM2mRNA translationp53RNA-binding proteinsRNA metabolism

Identifiers

PMID34573428
PMCPMC8465283
OpenAlexW3200696174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.